Paris, France
The 14th International Conference on Gynecology and Obstetrics will be held on March 26–27, 2026, in Paris, France, bringing together leading researchers, clinicians, academicians, industry professionals, and policy makers to explore the latest advancements in women’s health. With the theme “Precision Medicine in Gynaecologic Cancers and Reproductive Disorders,” this global meeting aims to foster dialogue, collaboration, and knowledge exchange on cutting-edge innovations that are transforming patient care.
The conference will feature keynote lectures, plenary sessions, panel discussions, workshops, and poster presentations covering a wide spectrum of topics, including gynaecologic oncology, maternal health, reproductive endocrinology, minimally invasive surgery, digital health, and emerging diagnostic and therapeutic strategies. Special emphasis will be placed on precision medicine approaches—integrating genomics, biomarkers, and individualized treatment pathways to improve outcomes in gynaecologic cancers and reproductive disorders.
Set against the inspiring backdrop of Paris, a city renowned for its cultural heritage and scientific spirit, this conference provides an ideal platform for building collaborations, exchanging ideas, and advancing innovations that shape the future of obstetrics and Gynecology worldwide.
1. Gynecology and Obstetrics: Foundations and Advances:
This track explores the core principles and evolving practices in gynecology and obstetrics, integrating clinical expertise with scientific advancements to improve women’s health. Topics include preventive strategies, diagnostic innovations, and multidisciplinary approaches to care. Emphasis will be placed on bridging traditional knowledge with modern techniques to enhance outcomes across maternal, fetal, and reproductive health.
Sub-tracks: Preventive gynecology • Advances in obstetric care • Multidisciplinary approaches
2. Menstrual Cycle, Ovulation, and Reproductive Physiology:
Focusing on the biological and hormonal regulation of menstruation and ovulation, this track examines normal physiology, disruptions, and their clinical implications. Discussions will highlight emerging diagnostic tools, hormonal therapies, and fertility management strategies. Advances in menstrual health research, menstrual irregularities, and ovulation induction will also be addressed to support reproductive well-being.
Sub-tracks: Menstrual irregularities • Hormonal regulation and therapies • Ovulation and fertility management
3. Gynecologic Oncology: Precision Therapies and Innovations:
This track delves into precision medicine approaches in gynecologic cancers, including ovarian, cervical, and endometrial cancers. It emphasizes molecular diagnostics, targeted therapies, immunotherapy, and fertility-sparing interventions. Experts will also discuss personalized treatment plans, clinical trial innovations, and survivorship strategies. The session provides a platform to share breakthroughs that are redefining cancer management.
Sub-tracks: Targeted therapies and immunotherapy • Fertility-sparing oncology • Biomarker-driven clinical trials
4. Pediatric and Adolescent Gynecology: Emerging Challenges:
This track addresses unique gynecological concerns in pediatric and adolescent populations, ranging from puberty disorders to reproductive health education. It will focus on early diagnosis, age-appropriate treatments, and safeguarding the reproductive future of young patients. Preventive strategies, menstrual health management, and psychosocial considerations will also be highlighted.
Sub-tracks: Puberty and menstrual disorders • Adolescent reproductive health • Psychosocial aspects in young patients
5. Urogynecology and Pelvic Floor Disorders:
This track examines pelvic floor dysfunction, urinary incontinence, and prolapse with a focus on innovative diagnostics and treatment approaches. It highlights minimally invasive surgical techniques, rehabilitation therapies, and lifestyle-based interventions. Advancements in imaging, biomaterials, and pelvic reconstructive procedures will also be discussed to enhance patient outcomes and quality of life.
Sub-tracks: Urinary incontinence management • Pelvic floor reconstruction • Minimally invasive urogynecology
6. Advancements in Prenatal Diagnostics and Screening:
This session explores cutting-edge prenatal diagnostic technologies, including non-invasive prenatal testing (NIPT), genetic screening, and fetal imaging. Discussions will focus on early detection of anomalies, ethical implications, and integration into routine obstetric practice. Emphasis will also be given to balancing diagnostic accuracy with patient safety and informed decision-making.
Sub-tracks: Non-invasive prenatal testing • Fetal imaging innovations • Genetic counseling in prenatal care
7. Maternal-Fetal Medicine: Innovations and Outcomes:
Focusing on high-risk pregnancies and fetal interventions, this track covers maternal-fetal interactions, prenatal therapies, and outcome-based approaches. It highlights recent advances in managing complications such as preeclampsia, gestational diabetes, and fetal growth restrictions. Experts will share evidence-based practices that improve maternal and neonatal health outcomes.
Sub-tracks: High-risk pregnancy management • Fetal therapy and interventions • Maternal complications and outcomes.
8. Midwifery and Obstetrical Nursing in Modern Care:
This track underscores the evolving role of midwives and nurses in maternal and newborn care. It highlights evidence-based practices, patient-centered care, and integration of modern technologies into midwifery and nursing practice. Sessions will also address workforce training, patient education, and collaborative models to enhance safe and respectful childbirth.
Sub-tracks: Evidence-based midwifery • Nursing innovations in obstetrics • Collaborative maternal care models.
9. Gynecological Disorders: Endometriosis, Fibroids, and PCOS:
This track focuses on common gynecologic conditions that impact fertility, quality of life, and overall health. It will explore advancements in diagnosis, medical and surgical management, and precision-based therapies for endometriosis, fibroids, and polycystic ovary syndrome (PCOS). Patient-centered strategies to improve reproductive outcomes and quality of life will be emphasized.
Sub-tracks: Endometriosis management • Fibroid treatment innovations • PCOS and fertility solutions
10. Minimally Invasive and Robotic Gynecologic Surgery:
This track highlights the latest advancements in minimally invasive surgical techniques, including laparoscopy, hysteroscopy, and robotic-assisted surgery. Sessions will explore improved surgical precision, faster recovery times, and patient safety measures. Clinical case studies and live demonstrations will provide practical insights into integrating these technologies into everyday practice.
Sub-tracks: Robotic gynecologic surgery • Laparoscopic and hysteroscopic innovations • Enhanced recovery protocols
11. Preterm Birth: Risk Assessment and Prevention Strategies:
Preterm birth remains a major global challenge in obstetrics. This track focuses on identifying risk factors, early interventions, and innovative prevention strategies. Experts will discuss the role of biomarkers, maternal health optimization, and evidence-based treatments to reduce preterm birth rates and improve neonatal outcomes.
Sub-tracks: Risk assessment and biomarkers • Prevention strategies • Neonatal outcomes after preterm birth
12. Spontaneous Abortion, Miscarriage, and Recurrent Pregnancy Loss:
This track explores the biological, genetic, and environmental causes of pregnancy loss. It emphasizes diagnostic innovations, preventive care, and emotional support strategies for affected families. Advances in genetic testing, immunologic evaluation, and reproductive technologies will be highlighted to reduce recurrence and improve live birth rates.
Sub-tracks: Genetic and immunologic causes • Preventive care strategies • Emotional and psychological support
13. Reproductive Endocrinology and Infertility Treatments:
This track focuses on hormonal regulation, reproductive endocrinology, and modern infertility treatments. Discussions include assisted reproductive technologies (ART), fertility preservation, and advances in ovulation induction. Emphasis will be on precision-based approaches that optimize outcomes and improve patient safety.
Sub-tracks: Assisted reproductive technologies • Hormonal therapies in infertility • Fertility preservation techniques
14. Menopause, Healthy Aging, and Hormone Replacement Therapy:
This track addresses the challenges and opportunities in managing menopause and promoting healthy aging. It covers hormone replacement therapy, non-hormonal treatments, and lifestyle-based interventions. Sessions will also highlight long-term health risks such as osteoporosis, cardiovascular disease, and mental health concerns in postmenopausal women.
Sub-tracks: Hormone replacement therapy • Non-hormonal interventions • Long-term health after menopause
15. Future Directions: Precision Medicine, Digital Health, and AI in OBGYN:
This track explores transformative innovations shaping the future of gynecology and obstetrics. Topics include genomic medicine, artificial intelligence applications, digital health tools, and predictive analytics. Experts will highlight how these technologies are enhancing diagnostics, personalizing treatment, and advancing global women’s health.
Sub-tracks: Artificial intelligence in OBGYN • Genomic and precision medicine • Digital health innovations.
The global gynecology and obstetrics market is witnessing steady growth, driven by rising demand for advanced maternal care, minimally invasive procedures, and precision medicine in gynaecologic cancers and reproductive disorders. According to recent industry reports, the women’s health market is projected to surpass USD 70 billion by 2030, with significant contributions from diagnostics, surgical devices, assisted reproductive technologies, and digital health solutions. Increasing prevalence of gynaecological disorders such as endometriosis, fibroids, and PCOS, along with a growing global burden of cervical and ovarian cancers, is further accelerating innovation in this field.
In obstetrics, challenges such as preterm birth, maternal mortality, and pregnancy complications continue to drive research into early diagnostics, fatal monitoring, and maternal-fatal interventions. Rapid adoption of AI, robotics, and genomic medicine is transforming patient care and offering new opportunities for precision-based approaches. With greater awareness, supportive healthcare policies, and rising investments in women’s health, the demand for specialized gynaecologic and obstetric services is expected to expand significantly, particularly in emerging markets.
London, UK - Nov 6, 2025
Paris, France - Mar 26, 2026
Paris, France - Mar 26, 2026
Meet Experts
Global Networking
Learning In a New Space
New Tips & Tactics
Certification
© 2025-2016 Meetings International. All Rights Reserved